INSIGHTS ON SOLID DOSE MANUFACTURING

• An Alternative Method Of Drug-Excipient Characterization

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Solubility Enhancement Via Amorphous Solid Dispersions

  Polyvinyl alcohol (PVA) is a versatile polymer platform used to enhance solubility through hot melt extrusion. Explore the role it plays in drug solubility, hydrolysis, and thermal behaviors.

• Bottling Solutions

  Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.

• The Future Of Oral Solid Dose Development And Innovation

  Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

• Innovative ASD Technology Improves Abandoned Cancer Medication

  3/1/2024

  Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

• Innovations In Dosage Form Design Pediatrics & Patients With Dysphagia

  7/17/2024

  With a focus on oral dosage form design for pediatrics and patients with dysphagia, Adare Pharma Solutions’ technologies and capabilities offer unique solutions to the pharmaceutical industry, ensuring improved drug delivery and patient experience.

• Overload Setting – Tricks And Techniques

  9/23/2024

  Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.

• How High Drug Load Nanocrystalline Tablets Lower Pill Burden

  3/12/2025

  We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  2/3/2025

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.